Skip to content
MedsAcross

Medicine

Lidocaine 200 mg/20 mL injection

Lidocaine · Intravenous
Available on requestPrescription onlyUS FDAGeneric name

Lidocaine 200 mg/20 mL injection is a generic prescription medicine for intravenous use, made by 2 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

All solutions should be stored at 20°C to 25°C (68°F to 77°F), excursions…

Key facts

Active ingredient (INN)
Lidocaine
Brand
Sold under the generic name
Strength
200 mg/20 mL
Dosage form
Injection
Route
Intravenous
Packs
25 vials of 20 mL, 10 vials of 20 mL
Manufacturers
Brookfield PharmaceuticalsHuons
Origin register
US FDA, United States
Storage
All solutions should be stored at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C to 30°C (59°F to 86°F). Protect from light.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
C01BB01 Lidocaine
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
9 May 2025
Identifiers
RxCUI 1010033, 1010671, 1737566 +1DailyMed set ID 8ec2d256-fc4f-44f6-bee2-eef2bf3bf580, e824ba5b-3289-5ad4-e053-2995a90acc20NDC 73293-0004, 71351-026Application ANDA212821

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
25 vial in 1 box / 20 mL in 1 vial71351-026-25Brookfield Pharmaceuticals27 November 2025
10 vial in 1 box / 20 mL in 1 vial73293-0004-2Huons9 May 2025
25 vial, multi-dose in 1 carton / 20 mL in 1 vial, multi-dose55150-252-20—30 October 2017
25 vial, multi-dose in 1 carton / 20 mL in 1 vial, multi-dose55150-252-24—30 October 2017
25 vial in 1 carton / 20 mL in 1 vial83854-009-26—29 December 2025
25 vial, multi-dose in 1 carton / 20 mL in 1 vial, multi-dose31722-116-31—8 November 2021
10 vial, multi-dose in 1 carton / 20 mL in 1 vial, multi-dose31722-116-32—13 December 2023
5 vial in 1 carton / 20 mL in 1 vial70756-646-05—14 September 2023
10 vial in 1 carton / 20 mL in 1 vial70756-646-10—14 September 2023
25 vial in 1 carton / 20 mL in 1 vial70756-646-25—14 September 2023
1 vial in 1 carton / 20 mL in 1 vial70756-646-87—14 September 2023
10 vial, multi-dose in 1 carton / 20 mL in 1 vial, multi-dose0143-9172-10—20 May 2025
25 vial, multi-dose in 1 tray / 20 mL in 1 vial, multi-dose0409-4276-01—16 August 2005
20 mL in 1 vial, multi-dose51662-1465-1—13 December 2019
25 pouch in 1 case / 1 vial, multi-dose in 1 pouch / 20 mL in 1 vial, multi-dose51662-1591-3—13 July 2022
25 pouch in 1 case / 1 vial, multi-dose in 1 pouch / 20 mL in 1 vial, multi-dose51662-1645-3—12 August 2010
5 vial, multi-dose in 1 bag / 20 mL in 1 vial, multi-dose55154-0124-5—30 March 2010
5 vial, multi-dose in 1 bag / 20 mL in 1 vial, multi-dose55154-8337-5—30 October 2017
1 vial, multi-dose in 1 bag / 20 mL in 1 vial, multi-dose0404-9763-20—19 March 2026
1 vial, multi-dose in 1 bag / 20 mL in 1 vial, multi-dose0404-9888-20—12 January 2022
1 vial, multi-dose in 1 bag / 20 mL in 1 vial, multi-dose71872-7184-1—22 November 2019
1 vial, multi-dose in 1 bag / 20 mL in 1 vial, multi-dose71872-7315-1—6 October 2023
25 vial, multi-dose in 1 carton / 20 mL in 1 vial, multi-dose83634-651-20—15 February 2026
25 vial, multi-dose in 1 carton / 20 mL in 1 vial, multi-dose72603-722-25—1 February 2025
20 mL in 1 vial, multi-dose84549-276-01—19 September 2025
25 vial, multi-dose in 1 carton / 20 mL in 1 vial, multi-dose23155-940-41—15 October 2025

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 19 November 1948Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Lidocaine 200 mg/20 mL injection.

Compare all 3

Other strengths and forms of Lidocaine

Clinical summary

Lidocaine is an amide local anesthetic. It is available as injection, ointment and patches for infiltration, perineural and topical use. MedsAcross supplies Lidocaine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Lidocaine

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Lidocaine 200 mg/20 mL injection for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.